Literature DB >> 15126108

Expression of IAP family proteins in esophageal cancer.

Tetsuo Nemoto1, Masanobu Kitagawa, Maki Hasegawa, Satoshi Ikeda, Takumi Akashi, Touichiro Takizawa, Katsuiku Hirokawa, Morio Koike.   

Abstract

Members of the inhibitor of apoptosis protein (IAP) family, including survivin, have been reported to be expressed in many tumors. However, their expression in esophageal cancer has not been clarified completely. We investigated the expression of mRNA for IAP family proteins in samples from esophageal cancers and their adjacent normal mucosa tissues by real-time quantitative RT-PCR. The survivin expression in esophageal cancer was significantly higher than that in normal mucosa (P < 0.05). Other IAP family proteins including cIAP1, cIAP2, NAIP and XIAP tended to show stronger expression in cancer tissue than normal mucosa, although the differences were not significant. As to the histological type of tumor, poorly differentiated squamous cell carcinomas exhibited significantly higher level of expression than well-differentiated carcinomas (P < 0.05). The proportion of apoptotic cells of cancer tissue inversely correlated with the intensity of survivin expression (P < 0.05). Immunohistochemical staining demonstrated cytoplasmic as well as nuclear expression of survivin in esophageal cancer, and further, in situ hybridization analysis demonstrated cytoplasmic expression of mRNA for survivin. The results suggest that the expression of IAP family proteins, especially survivin, may be associated with the biological character of esophageal cancer, such as apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126108     DOI: 10.1016/j.yexmp.2004.01.001

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  21 in total

1.  Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma.

Authors:  Li-Qun Gu; Feng-Ying Li; Lin Zhao; Yun Liu; Qian Chu; Xun-Xiong Zang; Jian-Min Liu; Guang Ning; Yong-Ju Zhao
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancer.

Authors:  Levent Dizdar; Lisa M Jünemann; Thomas A Werner; Pablo E Verde; Stephan E Baldus; Nikolas H Stoecklein; Wolfram T Knoefel; Andreas Krieg
Journal:  Oncol Lett       Date:  2018-01-09       Impact factor: 2.967

3.  X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton.

Authors:  Jinyi Liu; Dongyun Zhang; Wenjing Luo; Yonghui Yu; Jianxiu Yu; Jingxia Li; Xinhai Zhang; Baolin Zhang; Jingyuan Chen; Xue-Ru Wu; Germán Rosas-Acosta; Chuanshu Huang
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

4.  MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.

Authors:  Ou Ma; Wei-Wen Cai; Lars Zender; Tajhal Dayaram; Jianhe Shen; Alan J Herron; Scott W Lowe; Tsz-Kwong Man; Ching C Lau; Lawrence A Donehower
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

5.  X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis.

Authors:  Zipeng Cao; Ruowen Zhang; Jingxia Li; Haishan Huang; Dongyun Zhang; Jingjie Zhang; Jimin Gao; Jingyuan Chen; Chuanshu Huang
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

6.  E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity.

Authors:  Jinyi Liu; Dongyun Zhang; Wenjing Luo; Jianxiu Yu; Jingxia Li; Yonghui Yu; Xinhai Zhang; Jingyuan Chen; Xue-Ru Wu; Chuanshu Huang
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

Review 7.  Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.

Authors:  Yan Liu; Lin Li; Haiyan Qi; Yan Gao; Sha Liu; Chongan Xu
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

8.  Role of positive selection in functional divergence of mammalian neuronal apoptosis inhibitor proteins during evolution.

Authors:  Fanzhi Kong; Zhaoliang Su; Chenglin Zhou; Caixia Sun; Yanfang Liu; Dong Zheng; Hongyan Yuan; Jingping Yin; Jie Fang; Shengjun Wang; Huaxi Xu
Journal:  J Biomed Biotechnol       Date:  2011-11-10

9.  Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate.

Authors:  Gonzalo Rodríguez-Berriguete; Benito Fraile; Fermín R de Bethencourt; Angela Prieto-Folgado; Nahikari Bartolome; Claudia Nuñez; Bruna Prati; Pilar Martínez-Onsurbe; Gabriel Olmedilla; Ricardo Paniagua; Mar Royuela
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

Review 10.  NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions.

Authors:  Nidhi Sharma; Sushmita Jha
Journal:  Cell Mol Life Sci       Date:  2015-12-26       Impact factor: 9.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.